vaccine development Archives | Nexcelom Bioscience

Dissecting the Genetic Code of SARS-CoV-2 with Reverse Genetics
Gallery
Dissecting the Genetic Code of SARS-CoV-2 with Reverse Genetics

Celigo, Celigo Application News, Latest News, Virology

Dissecting the Genetic Code of SARS-CoV-2 with Reverse Genetics

The COVID-19 pandemic has increased SARS-CoV-2 research globally resulting in three publicly available vaccines from Moderna, Pfizer (mRNA-based), and Johnson & Johnson (viral vector-based).

By Victor Ocasio-Ramirez, PhD|2022-01-31T21:32:59+00:00April 7th, 2021|Categories: Celigo, Celigo Application News, Latest News, Virology|Tags: Celigo, covid-19, genetics, mRNA, SARS-CoV-2, vaccine development|0 Comments

High-throughput Microneutralization Method for Feline Coronavirus

The Celigo Image Cytometer reduces assay time while providing richer, quantitative readouts to accelerate assessment of vaccine and antiviral compound candidates.

By Rebecca Ste Croix|2022-01-31T21:32:40+00:00November 19th, 2020|Categories: Celigo, Instrument, Latest News, Virology|Tags: Celigo, coronavirus, High-Throughput, Image Cytometer, Imaging Cytometry, vaccine development, viral neutralization, viral plaque assay|0 Comments

Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?

Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.

By Polly Mitchell|2021-06-15T04:21:35+00:00March 23rd, 2020|Categories: Celigo, Celigo Application News, Instrument, Latest News, Virology|Tags: Celigo, coronavirus, covid-19, Image Cytometer, SARS-CoV-2, vaccine development, virology|0 Comments